Cryo-Cord is an umbilical cord product that is applied directly to a non-healing wound.
INTENDED USES: Cryo-Cord is typically used for chronic non-healing wounds or affected area. There are multiple product sizes; the provider uses the size that most closely matches the wound.
CLAIMED BENEFITS: Cryo-Cord is a cryopreserved product that serves as wound covering. Cryo-cord is minimally manipulated, semi-transparent, collagenous membrane allograft obtained with consent from healthy mothers during cesarean section delivery. Cryo-cord is derived from the umbilical cord.
The addition of Skin Substitutes or Cellular or Tissue Based Products (CTPs) to certain wounds may afford a healing advantage over dressings and conservative treatments when these options appear insufficient to affect complete healing, after at least a 30 day period of comprehensive conservative therapy. There are currently a wide variety of bioengineered products available for soft tissue coverage to affect closure. • Human skin allografts are derived from donated human skin (cadavers) • Allogeneic matrices are derived from human tissue (fibroblasts or membrane) • Composite matrices are derived from human keratinocytes, fibroblasts and xenogeneic collagen • Acellular matrices are derived from xenogeneic collagen or tissue
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care